P/E ratio for Vericel (VCEL)
P/E ratio as of July 2025 (TTM): 797
According to Vericel 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 797.2. At the end of 2024 the company had a P/E ratio of 275.
P/E ratio history for Vericel from 2001 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 275 | |
| 2022 | -75.3 | -69.36% |
| 2021 | -246 | -155.68% |
| 2020 | 441 | -683.12% |
| 2019 | -75.7 | -0% |
| 2018 | -75.7 | 635.7% |
| 2017 | -10.3 | 304.47% |
| 2016 | -2.54 | -4.41% |
| 2015 | -2.66 | 179.1% |
| 2014 | -0.9530 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Royalty Pharma RPRX | 15.1 | -98.10% | 🇬🇧 UK |
 Neogen NEOG | -2.16 | -100.27% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.